Nancy N. and J.C. Lewis Cancer and Resarch Pavilion at Saint Joseph's Candler.

Phone 800-622-6877

Oncology Clinical Trials

Title	Study/Treatment
BRAG-Onc - Medical College of Georgia Tumor Tissue and Serum Repository - Central Biorepository Alliance of Georgia-Oncology	Cancer
CALGB 140503 - A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (<=2 cm) Peripheral Non-Small Cell Lung Cancer	Lung Cancer
CALGB 30506 - A Randomized Phase III Trial to Evaluate the Capacity of a Genomic Prognostic Model to Identify Stage 1 NSCLC Patients as Candidates for Adjuvant Chemotherapy.	Lung Cancer
CALGB 30607 - Randomized, Phase III, Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Pts Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer	Lung Cancer
CALGB 30610/RTOG0538 - Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide	Lung Cancer
CALGB 40502 - A Randomized Phase III Trial of Weekly Paclitaxel Compared To Weekly Nanoparticle Albumin Bound Nab-Paclitaxel Or Ixabepilone Combined With Bevacizumab As First -Line Therapy For Locally Recurrent Or Metastatic Breast Cancer	Breast Cancer
CALGB 40601 - Randomized Phase III Trial of Paclitaxel Combined with Trastuzumab, Lapatinib or Both as Neoadjuvant Treatment of HER2-positive Primary Breast Cancer	Breast Cancer
CALGB 70604 - A Randomized, Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer	Cancer
CALGB 80405 - A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin / 5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with Combination of Bevacizumab and Cetuximab for Pts with Untreated Metastatic Adenocarcinoma of the Colon or Rectum	Colorectal Cancer
CALGB 80802 - PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH	Cancer
CALGB 90202 - A Randomized, Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone	Prostate Cancer
E1505 - A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (Y4cm)-IIIA Non-Small Cell Lung Cancer (NSCLC)	Lung Cancer
E2805 - ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma	Cancer
E5103 - A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer	Breast Cancer
E5202 - A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence Recurrence	Colorectal Cancer
Lung - Evaluation of Lung Cancer Screening Program and Patient Navigation in a Community Cancer Center: A time to treatment study	Lung Cancer
MCC 14690 - Total Cancer Care: A Partnership with High Risk and/or Diagnosed Cancer Patients for Life	Cancer
N063D, ALTTO - Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation Study: A Randomized, Multi-centre, Open-label, Phase III Study of Adjuvant Lapatinib, Trastuzumab, Their Sequence and Combination in Pts with HER2/ErbB2 Pos Primary Breast Cancer	Breast Cancer
NSABP B-39/RTOG0413 - A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer	Breast Cancer
NSABP B-43 - A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma in Situ Resected by Lumpectomy	Breast Cancer
NSABP R-04 - Carcinoma of the Rectum	Colorectal Cancer
RTOG 0232 - Intermediate Risk Prostatic Carcinoma	Prostate Cancer
S0230 - Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer	Breast Cancer
S0424 - Non-Small Cell Lung Cancer in Smoking/Non-Smoking Men and Women	Lung Cancer
S0635 - A Phase II Trial of the Combination of OSI-774 (Erlotinib; NSC-718781) and Bevacizumab (rhuMAb VEGF; NSC-704865) in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma with BAC Features (ADENOBAC)	Lung Cancer
S0636 - A Phase II Trial of the Combination of OSI-774 (Erlotinib; NSC-718781) and Bevacizumab (rhuMAb VEGF; NSC-704865) in NEVER-SMOKERS with Stage IIIB and IV PRIMARY NSCLC ADENOCARCINOMAS	Lung Cancer
S0715 - Randomized Placebo-Controlled Trial of Acetyl L-Carnitine for the Prevention of Taxane Induced Neuropathy	Breast Cancer
S0727 - A Phase I and Randomized Phase II Trial of Gemcitabine + Erlotinib (NSC-718781) + IMC-A12 (NSC-742460) vs. Gemcitabine + Erlotinib as First-Line Treatment in Patients with Metastatic Pancreatic Cancer	Pancreatic Cancer
S0819 - A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)	Lung Cancer
TAILORx Trial	Breast Cancer
Treatment of Chemotherapy-Induced Nausea with Acupressure: A Phase III Trial	Cancer Control and Prevention
Z4051 - A Phase II Study of Neoadjuvant Therapy with Cisplatin, Docetaxel, Panitumumab Plus Radiation Therapy Followed by Surgery in Patients with Locally Advanced Adenocarcinoma of the Distal Esophagus	GI Tract Cancer